News
12-19-2011, 09:31 AM
Generex Biotechnology Corporation today announced that Bloomberg Television is scheduled to air a segment on the immunotherapeutic breast cancer vaccine being developed by its wholly-owned subsidiary, Antigen Express, Inc.
More... (http://www.news-medical.net/news/20111219/Bloomberg-TV-to-air-segment-on-Antigen-Express-immunotherapeutic-breast-cancer-vaccine.aspx)
More... (http://www.news-medical.net/news/20111219/Bloomberg-TV-to-air-segment-on-Antigen-Express-immunotherapeutic-breast-cancer-vaccine.aspx)